Analyst Terence Flynn of Morgan Stanley maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), retaining the price target ...

Repare Therapeutics Inc. (NASDAQ: RPTX) disclosed significant strategic adjustments in a recent SEC 8-K filing. The precision oncology company declared preliminary unaudited financial data, indicating ...

As top pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Conference next week, biotech ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...